Cancer Immunology, Immunotherapy Issues Research Articles in May 2022 Edition
April 19, 2022
April 19, 2022
BASEL, Switzerland, April 19 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles on the following topics in its May 2022 edition:
Original Articles:
* EGFR mutation status in non-small cell lung cancer receiving PD-1/PD-L1 inhibitors and its correlation with PD-L1 expression: a meta-analysis
* Defective NK cell expansion, cytotoxicity, and lack of ability to differ . . .
Original Articles:
* EGFR mutation status in non-small cell lung cancer receiving PD-1/PD-L1 inhibitors and its correlation with PD-L1 expression: a meta-analysis
* Defective NK cell expansion, cytotoxicity, and lack of ability to differ . . .